Endoscopy Devices: Applications and Global Markets

Report Highlights

The endoscopy market worldwide was $23.3 billion in 2010 and is projected to reach nearly $24.8 billion in 2011. This is further anticipated to increase to $33.7 billion by 2016 at a compound annual growth rate (CAGR) of 6.4%.

Report Scope

Current and projected endoscopy revenue forecasts during the forecast period (2011 to 2016) are discussed.  Endoscopy devices require U.S. Food and Drug Administration FDA premarket manufacturing notification (PMN) approval, European Union Medical Device Directive European Conformity (CE Mark) approval, or similar approvals in other countries.  Regulation on endoscopic devices is rigid in terms of proving proof of product safety and efficacy before sale to the medical community.  Due to the timing of the release of this report, the figures for 2011 are estimated, except where actual results have been reported.

The report includes analysis of the leading competitors, as well as emerging companies in the current worldwide endoscopy market.  Profiles of the manufacturers of the leading products are analyzed, their specific product strategies are outlined, and their pipeline of products is discussed.  This report looks at companies poised to introduce new products during the forecast period and discusses how these products may change the face of the competitive environment.  This competitive environment is examined with special focus on how developing products and technologies are influencing the current standard of patient care.  Detailed profiles of the current market leaders and emerging companies are discussed in detail.

Market figures are based on revenues at the manufacturers’ level and are projected in 2010-dollar value.  Inflation is not calculated in the projection figures.  Trends are assessed based on a number of parameters, including projected sales for existing products, new product introductions, expanded indications for existing products, and finally, for projected changes in the prevalence, diagnosis, and scripting rates for certain diseases.

Included in this report are forecasts by product, disease category, and by company for the period from 2011 through 2016.  The report is arranged to provide an overview of the endoscopy market by product, company, and geography.  Forecasts are broken down by geographic region or by country.  The worldwide market is analyzed and data provided for each disease subsegment.

Sales figures are reported in U.S. dollars and in each case reflect currency fluctuations within the performance of revenue change.  Revenue figures do not account for variation in local currencies.

All market share data presented is on a global basis unless specifically noted.

Analyst Credentials

Jackson Highsmith is a life sciences research consultant with more than 16 years of research experience. Jackson has been consulting with specialty pharmaceuticals and large pharmaceutical industry players since 2007. Prior to that, he worked at a large research consultancy, where he focused on in-depth research; he also has worked at a large pharmaceutical company in a wide range of medical therapeutics in early- and mid-stage drug development. Jackson Highsmith is a pseudonym of the author.